The world’s first clinical trial of the manufactured red blood cells!

 | Post date: 2022/11/10 | 
A research team at the University of Cambridge and NHS Blood and Transplant conducted the world’s first clinical trial of red blood cells that have been grown in a laboratory for transfusion into another person. The manufactured blood cells were grown from stem cells from donors. The red cells were then transfused into volunteers in the RESTORE randomised controlled clinical trial. This is the first time in the world that red blood cells that have been grown in a laboratory have been given to another person as part of a trial into blood transfusion. The trial is studying the lifespan of the lab grown cells compared with infusions of standard red blood cells from the same donor. The lab-grown blood cells are all fresh, so the trial team expect them to perform better than a similar transfusion of standard donated red cells, which contains cells of varying ages. If this trial, the first such in the world, is successful, it will mean that patients who currently require regular long-term blood transfusions will need fewer transfusions in future, helping transform their care. 
Read more



CAPTCHA

View: 114 Time(s)   |   Print: 22 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)


© 2023 CC BY-NC 4.0 | Modern Medical Laboratory Journal